Status:
UNKNOWN
Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
Lead Sponsor:
Chattogram General Hospital
Collaborating Sponsors:
Xi'an Jiaotong University
Conditions:
Covid19
ARDS
Eligibility:
All Genders
20-80 years
Phase:
PHASE3
Brief Summary
A randomized clinical trial designed and intended to evaluate the efficacy of Dexamethasone and Methylprednisolone as a treatment for severe Acute Respiratory Distress Syndrome (ARDS) caused by corona...
Eligibility Criteria
Inclusion
- • Moderate to severe COVID-19 requires hospitalization. SARS-CoV-2 infection will be confirmed by RT PCR / CT Chest in every case.
Exclusion
- Participants with uncontrolled clinical status who were hospitalized from the before.
- Contraindication / possible drug interaction.
- Participants who have any severe and/or uncontrolled medical conditions like, Severe ischemic heart disease, epilepsy, malignancy, Pulmonary/renal/hepatic disease, pregnancy, Corpulmonale, etc.
Key Trial Info
Start Date :
August 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04499313
Start Date
August 2 2020
End Date
November 30 2020
Last Update
August 18 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Chattogram General Hospital
Chittagong, Bangladesh, 4000
2
M. Abdur Rahim Medical College Hospital
Dinajpur, Bangladesh